Georgetown Receives FDA Clearance for Trial with Nilotinib in Alzheim

Thread Tools

Display Modes

10-01-2016, 03:26 PM

zanpar321

Member

Join Date: Feb 2014

Posts: 365

zanpar321

Member

Join Date: Feb 2014

Posts: 365

Georgetown Receives FDA Clearance for Trial with Nilotinib in Alzheim

It's for Alzheimer's but may be an early look at Parkinson's

Georgetown Receives FDA Clearance to Conduct Clinical Trial with Nilotinib in Alzheimer’s Disease | Georgetown University Medical Center | Georgetown University

Reply With Quote

"Thanks for this!" says:

eds195 (10-01-2016), olsen (10-06-2016), Tupelo3 (10-01-2016)

Tags

alzheimers, clearance, fda, parkinsons, receives

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

Similar Threads
Thread	Thread Starter	Forum	Replies	Last Post
A third clincal trial site for Nilotinib receives FDA approval	Tupelo3	Parkinson's Disease	0	09-14-2016 01:54 PM
Six month follow up on Nilotinib trial.	Betsy859	Parkinson's Disease	30	07-17-2016 05:52 PM

All times are GMT -5. The time now is 12:55 PM.

NeuroTalk Forums

Helping support those with neurological and related conditions.

All posts copyright their original authors.

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.

Always consult your doctor before trying anything you read here.

Site Navigation

NeuroTalk Online Support Groups

Georgetown Receives FDA Clearance for Trial with Nilotinib in Alzheim

NeuroTalk Forums